Reuters logo
BRIEF-Innate Immunotherapeutics' FY loss before income tax widens to $7.1 mln
May 30, 2017 / 11:17 PM / in 7 months

BRIEF-Innate Immunotherapeutics' FY loss before income tax widens to $7.1 mln

May 31 (Reuters) - Innate Immunotherapeutics Ltd

* FY loss before income tax $7.1 million versus loss of $ 4.9 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below